Skip to main content
Thoracic Cancer logoLink to Thoracic Cancer
. 2019 Jun 27;10(8):1669–1672. doi: 10.1111/1759-7714.13092

Comparison of postoperative complications between different operation methods for esophageal cancer

Qingqing Ding 1, Wenyin Zhou 2, Yibo Xue 3, Xiao Han 1, Dandan Yin 1, Lei Xue 3,†,, Jinhua Luo 3,†,
PMCID: PMC6669799  PMID: 31245903

Abstract

Background

We explored the selection of surgical method and differences in postoperative complications in patients with esophageal cancer (EC).

Methods

The data of 434 patients with EC who underwent thoracic surgery at the Jiangsu Provincial People's Hospital between January 2011 and December 2016 were collected. Patients were divided into three groups: Sweet surgery (143 cases), Ivor–Lewis surgery (232 cases), and minimally invasive esophagectomy (MIE, 59 cases). The number of postoperative days, number of lymph nodes dissected, and incidence of pulmonary infection, serous membrane fluid, arrhythmia, chylous fistula, gastric emptying dysfunction, and anastomotic leakage were recorded.

Results

A statistically significant number of female stage I patients with upper EC underwent MIE (P < 0.05). Postoperative complications were observed in all three groups but were not statistically significant (P > 0.05). A greater number of lymph nodes were dissected in the Ivor–Lewis group compared to the other groups (P < 0.05).

Conclusion

Clinically, MIE is often selectively used for women with upper and mid‐early EC, especially in stage I. In our sample, more lymph nodes were dissected in the Ivor–Lewis than in the MIE group, which can reduce recurrence and improve the survival rate. Ivor–Lewis surgery is often used in mid‐lower and terminal EC, while MIE is often used in upper and mid‐early EC. Compared to the other surgical methods, MIE does not increase the risk of postoperative complications. The gradual maturation of MIE technology will further expand indications and increase the number of lymph nodes dissected.

Keywords: Complication, esophageal cancer, esophagectomy

Introduction

Esophageal cancer (EC) has a high incidence worldwide, ranking eighth in morbidity and sixth in mortality.1, 2 The majority of EC cases in China are squamous cell carcinoma, which is very common in men and is often detected at middle or late stage. Surgical treatment remains the first choice. Presently, the main radical surgical methods for EC include: Sweet surgery (left thoracic, one incision), Ivor–Lewis surgery (right chest posterolateral and upper abdomen median, two incisions), and minimally invasive esophagectomy (MIE). In this study, we retrospectively analyzed 434 cases of different esophagectomy methods and observed the different effects and complications after surgery to provide a reference for the surgical selection of EC.

Methods

Patients

Between January 2011 and December 2016, 434 patients were scheduled for surgery for EC at our Department of Thoracic Surgery. The patients were divided into three groups: Sweet surgery (left thoracic, one incision, 143 cases), Ivor–Lewis surgery (right chest posterolateral and upper abdomen median, two incisions, 232 cases), and MIE (59 cases). Postoperative EC staging was based on the 7th edition American Joint Committee on Cancer (AJCC) Cancer Staging Manual.

Patients were pathologically confirmed with EC after surgery and were included in the study if preoperative imaging examination showed no obvious tumor invasion of surrounding tissues or distant metastasis, and organ function was tolerable to surgery. Patients with tumor invasion; distant metastasis; heart, kidney, lung and other functional abnormalities; serious infection of the body; and other malignant tumors were excluded.

The ethics committee of our hospital approved this study and patients and their families signed informed consent.

Esophagectomy procedure

Sweet

All operations were performed via the left thorax. One postural change was performed intraoperatively and one surgical field disinfection. The right lateral position was taken to free the esophagus from the left thoracic cavity, the diaphragm was cut open, the stomach was dislodged from the abdomen, the esophagus was cut off, the free stomach was pulled from the abdominal cavity to the thoracic cavity, and the tubular stomach was made. Finally, the tubular stomach was anastomosed with the esophagus in the thoracic cavity and the diaphragm was sutured.

Ivor–Lewis

The right upper right thorax incision and two postural changes were performed intraoperatively, with two surgical field disinfections. The stomach was dissected from the abdomen and the abdominal lymph nodes were dissected in the supine position. The esophagus and mediastinal lymph nodes were dissected from the right thoracic cavity in the left lateral position. The esophagus was cut off and the dissected stomach was pulled from the abdominal to the thoracic cavity through the hiatus of the esophagus to make a tubular stomach.

Minimally invasive esophagectomy (MIE)

Cervicothoracic and abdominal incisions were performed via endoscopy. Two postural changes were performed intraoperatively and two surgical field disinfections. The esophagus and mediastinal lymph nodes were dissected from the right thoracic cavity in the left lateral position, and then the upper esophagus was dissected and cut off in the left cervical incision. The stomach was dissected from the abdomen, and the tubular stomach was made to replace the esophagus. The abdominal lymph nodes were dissected. Finally, the tubular stomach was extracted from the left neck from the abdomen through the right thoracic esophageal bed to the left neck, and the tubular stomach and esophagus were anastomosed from the neck.

Statistical analysis

The number of postoperative days, number of lymph nodes dissected, and the incidence of pulmonary infection, serous membrane fluid, arrhythmia, chylous fistula, gastric emptying dysfunction, and anastomotic leakage in the three groups were recorded and compared. Data were processed using SPSS version 23.0. The counting data were expressed as percentages, and chi‐square and Fisher's exact probability tests were used for comparison between groups. Measurement data were indicated with x ± s, using one‐way analysis of variance. P < 0.05 was considered statistically significant.

Results

The clinical data of different surgical methods in EC patients were compared. Postoperative pathological data of the patients is shown in Table 1. A statistically significant number of female stage I patients with upper EC underwent MIE (P < 0.05).

Table 1.

Clinical data of different surgical methods in 434 patients with esophageal cancer

Characteristics Sweet (n = 143) (%) Ivor–Lewis (n = 232) (%) MIE (n = 59) (%) χ 2 P
Gender 8.227 0.016
Male 111(77.6) 163(70.3) 34(57.6) ND ND
Female 32(22.4) 69(29.7) 25(42.4) ND ND
Tumor 84.179 < 0.001
Upper 4(2.8) 4(1.7) 12(20.3) ND ND
Middle 39(27.3) 138(59.5) 34(57.6) ND ND
Lower 100(69.9) 90(38.8) 13(22.1) ND ND
TNM staging 17.639 0.007
Stage I 31(21.7) 63(27.2) 24(40.7) ND ND
Stage II 57(39.9) 84(36.2) 21(35.6) ND ND
Stage III 43(30.1) 80(34.5) 13(22.0) ND ND
Stage IV 12(8.3) 5(2.1) 1(1.7) ND ND

MIE, minimally invasive esophagectomy; ND, no data; TNM, tumor node metastasis.

The number of postoperative days, the number of lymph nodes dissected, and the incidence of pulmonary infection, serous membrane fluid, arrhythmia, chylous fistula, gastric emptying dysfunction and anastomotic leakage in the three groups are shown in Table 2. A significantly higher number of lymph nodes were dissected in the Ivor–Lewis group than in the other two groups (P < 0.05). The number of postoperative days, and the occurrence of pulmonary infection, serous membrane fluid, arrhythmia, chylous fistula, gastric emptying dysfunction, and anastomotic leakage were not statistically significant between the groups (P > 0.05).

Table 2.

Comparison of postoperative complications between different surgical methods in patients with esophageal cancer

Outcome Sweet (n = 143) Ivor–Lewis (n = 232) MIE (n = 59) F P
Postoperative days (x ± s) 11.4 ± 2.7 12.0 ± 1.9 11.5 ± 1.8 3.641 0.27
Number of lymph nodes dissected (x ± s) 14.1 ± 7.8 19.8 ± 8.5 15.5 ± 7.3 23.365 < 0.001
Pulmonary infection (%) 51 (35.7) 93 (40.1) 29 (49.2) 3.18 0.204
Serous membrane fluid (%) 100 (69.9) 151 (65.1) 34 (57.6) 2.879 0.237
Arrhythmia (%) 35 (24.5) 35 (15.1) 11 (18.6) 5.138 0.077
Chylous fistula (%) 1 (1.0) 1 (0.4) 0 (0.0) 0.455 0.797
Gastric emptying dysfunction (%) 1 (1.0) 0 (0.0) 0 (0.0) 2.040 0.361
Anastomotic leakage (%) 2 (1.4) 4 (1.7) 0 (0.0) 1.026 0.599

MIE, minimally invasive esophagectomy.

Discussion

EC is one of the most common malignant tumors, both in China and worldwide, and is often discovered at middle or late stage. Methods to reduce the risk of surgery and postoperative complications3, 4 and to improve the thoroughness of the operation remain controversial.5, 6

The number of lymph nodes dissected is one of the most important indexes to evaluate the thoroughness of EC surgery, which is closely related to the total survival of patients.7, 8 Because of the disadvantages of lymph node dissection, the use of Sweet surgery has gradually been reduced. Ivor–Lewis surgery now is the main surgical method used for EC in China. In recent years, with the development of combined thoracoscopic and laparoscopic techniques, endoscopy has the potential advantages of less trauma, quicker recovery, and clear vision of the surgical field. Minimally invasive radical resection of EC has gradually been promoted in clinical practice.9

This study showed that, compared to the other two methods, Ivor–Lewis surgery is effective for the treatment of lymph nodes in EC patients and can reduce recurrence and improve survival. Our results were inconsistent with those of Peng et al., who suggested that a greater number of lymph nodes are dissected during MIE.10 However, compared to open surgery, Guo et al. reported that the incidence of anastomotic fistula after MIE surgery increased and the postoperative hospital stay was significantly prolonged.11 Our retrospective study showed that the postoperative complications after MIE were similar to those of the other two open surgery methods, and most of the patients considering endoscopic surgery were at early stage which reduces the risk of postoperative complications. This is consistent with results in research by Khan et al.2 In addition, fewer lymph nodes are dissected via MIE than by Ivor–Lewis surgery. Considering that MIE is primarily performed in women with early and upper EC, anastomotic fistula is prone to occur. The gradual maturity of MIE technology will further expand indications and increase the number of lymph nodes dissected.12, 13

In our study, early tumor stage, and female patients tended to undergo MIE. We posit that this is because female patients are generally small in size, short in the thoracic esophagus, and difficult in free esophagus and anastomosis. Early stage patients experience less tumor invasion and thus there is less risk of intraoperative injury to the aorta, bronchial membrane, and other important structures. Patients of advanced age and in late tumor stages are more likely to choose open surgery because lymph node dissection is easier to carry out under open conditions, and can better prevent bleeding, protect important organs, and control risk.

In conclusion, Ivor–Lewis surgery is considered to be more thorough for lymph node dissection than other surgical methods, and remains the mainstream surgical method.2 However, it is expected that with the increasing number of minimally invasive operations performed, the advantages of MIE will gradually emerge.

Disclosure

No authors report any conflict of interest.

Acknowledgments

The Project of the Nanjing Science and Technology Committee (201611005), the Project of the Qiangwei Youth Medical Talent of Jiangsu Provincial Commission of Health and Family Planning (QNRC2016594) and the Natural Science Foundation of Science and Technology, Department of Jiangsu Province (BK20161594) funded this study.

Contributor Information

Lei Xue, Email: raymond@163.com.

Jinhua Luo, Email: ljhua1966@126.com.

References

  • 1. Pan R, Zhu M, Yu C et al Cancer incidence and mortality: A cohort study in China, 2008‐2013. Int J Cancer 2017; 141 (7): 1315–23. [DOI] [PubMed] [Google Scholar]
  • 2. Khan O, Nizar S, Vasilikostas G, Wan A. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open‐label, randomised controlled trial. J Thorac Dis 2012; 4 (5): 465–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Xu J, Hu J. Clinical analysis of risk factors for postoperative anastomotic leakage in geriatric patients with esophageal carcinoma. Chin J Geriatr 2016; 35 (8): 876–9. [Google Scholar]
  • 4. Low DE, Alderson D, Cecconello I et al International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg 2015; 262 (2): 286–94. [DOI] [PubMed] [Google Scholar]
  • 5. Mao T, Fang W, Gu Z, Guo X, Ji C, Chen W. Comparison of perioperative outcomes between open and minimally invasive esophagectomy for esophageal cancer. Thorac Cancer 2015; 6 (3): 303–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Brown AM, Pucci MJ, Berger AC et al A standardized comparison of peri‐operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown. Surg Endosc 2018; 32 (1): 204–11. [DOI] [PubMed] [Google Scholar]
  • 7. Wang F, Duan H, Cai M et al Prognostic significance of the pN classification supplemented by body mass index for esophageal squamous cell carcinoma. Thorac Cancer 2015; 6 (6): 765–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Wu H, Liu C, Xu M, Guo MF, Xu SB, Xie MR. Prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis. Thorac Cancer 2018; 9 (9): 1129–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Du JJ, Meng L, Liu Q et al Clinical analysis of the treatment of middle thoracic esophageal cancer by hand assisted video thoracoscopy in the elderly. Chin J Geriatr 2005; 24 (8): 605–6. [Google Scholar]
  • 10. Peng X, Chen Y, Jumal AN et al Comparison of short‐term outcomes between minimally invasive McKeown esophagectomy and Ivor‐Lewis esophagectomy for esophageal cancer. J Cent South Univ(Med Sci) 2017; 42 (5): 546–52. [DOI] [PubMed] [Google Scholar]
  • 11. Guo W, Gong TQ, Jiang YG et al Analysis of the intraoperative and postoperative complications for 366 thoracoscopic esophagectomies. Chin J Thorac Cardiovasc Surg 2014; 30 (3): 145–8. [Google Scholar]
  • 12. Yerokun BA, Sun Z, Yang CJ et al Minimally invasive versus open esophagectomy for esophageal cancer: A population‐based analysis. Ann Thorac Surg 2016; 102 (2): 416–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Sihag S, Kosinski AS, Gaissert HA, Wright CD, Schipper PH. Minimally invasive versus open esophagectomy for esophageal cancer: A comparison of early surgical outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 2016; 101 (4): 1281–9. [DOI] [PubMed] [Google Scholar]

Articles from Thoracic Cancer are provided here courtesy of Wiley

RESOURCES